Biora Therapeutics Inc [BIOR] stock is trading at $1.24, up 7.83%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The BIOR shares have gain 18.10% over the last week, with a monthly amount glided 32.03%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 26, February 2024, Biora Therapeutics Announces Successful Completion of Single-Ascending Dose (SAD) Cohorts of Phase 1 Clinical Study of BT-600. In a post published today on Yahoo Finance, Data expected to be shared during March corporate update.
From an analyst’s perspective:
Biora Therapeutics Inc [BIOR] stock has fluctuated between $0.76 and $6.70 over the past year. Biora Therapeutics Inc [NASDAQ: BIOR] shares were valued at $1.24 at the most recent close of the market.
Analyzing the BIOR fundamentals
Biora Therapeutics Inc [NASDAQ:BIOR] reported sales of 0.02M for the trailing twelve months, which represents a drop of -100.00%. Gross Profit Margin for this corporation currently stands at -32.11% with Operating Profit Margin at -3754.17%, Pretax Profit Margin comes in at -6772.61%, and Net Profit Margin reading is -7041.56%. To continue investigating profitability, this company’s Return on Assets is posted at -3.65, Equity is 1.13 and Total Capital is 1.94. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-0.69.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.1576 points at the first support level, and at 1.0751 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.3149, and for the 2nd resistance point, it is at 1.3897.
Biora Therapeutics Inc [BIOR] reported earnings per share of -$4.89 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.92/share, meaning a difference of -$3.97 and a surprise factor of -431.50%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$1.47 per share as compared to estimates of -$1.6 per share, a difference of $0.13 representing a surprise of 8.10%.
Ratios To Look Out For
For context, Biora Therapeutics Inc’s Current Ratio is 0.28. Also, the Quick Ratio is 0.28, while the Cash Ratio stands at 0.18. Considering the valuation of this stock, the price to sales ratio is 1687.02.
